$EVRG

Evergy planning new power plants amid data center boom in Kansas

Evergy said it plans to seek Kansas regulators’ prior approval for three new generation assets in Kansas: a natural gas plant, a solar farm, and a battery storage facility, citing data center driven load growth. Evergy CEO David Campbell also referenced prior approvals and an updated Kansas IRP, plus Q2 adjusted earnings of about $209 million.

Original reporting
Published Aug 16, 2026, 9:02 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 16, 2026, 2:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Evergy planning new power plants amid data center boom in Kansas — source image
Decision brief

The 30-second read

$EVRGBullishMed
01

Why it matters

The key new trading angle is the planned Kansas predetermination application for three generation assets (new natural gas plant, solar farm, battery storage) and the IRP framing that a 910 MW gas turbine is the most critical near-term resource to close a residual capacity gap.

02

Market read

Traders should watch for the timing and content of Evergy’s Kansas predetermination filing and any regulatory signals that could affect rate-base growth and earnings visibility.

03

What to watch

Tariff-driven fuel and equipment cost risk is explicitly mentioned for prior gas plant approvals, which could pressure project economics and rate outcomes even if capacity is approved.

Relevance 6/10Novelty 6/10Timing: application planned later this year, with KCC predetermination filings referenced

Background

Evergy is a regulated utility serving much of eastern Kansas and western Missouri, and it is using large-load tariff frameworks tied to data center customer agreements.

Company-level read

Ticker impact

$EVRGBullishMedium confidence
Context

Evergy plans Kansas generation assets and seeks KCC predetermination approval, citing data-center load growth and a 910 MW gas turbine as critical.

Expected impact

Moderately positive bias for EVRG on expectations of approved rate recovery and load growth, with volatility tied to regulatory timing and project costs.

Evidence & confidence

The article discloses a specific planned KCC predetermination application (gas, solar, battery) and frames a 910 MW gas turbine as addressing a residual capacity gap, which can influence rate-base and earnings visibility. However, it does not provide a new approval decision, only intent and prior-approval context.

Market effects

Highlights continued hyperscaler-driven demand for utility capacity, supporting demand for generation, storage, and grid solutions in regulated power markets.

Kansas and eastern Missouri utilities face higher load growth from data centers, increasing likelihood of additional generation and transmission investment approvals.

Limited direct global impact, but reinforces the broader AI infrastructure power demand theme that can affect equipment and fuel demand narratives.

Counterpoint

Even with data-center ESAs, regulatory approval and siting constraints (notably solar zoning opposition) could delay or reduce the economics of the planned resource additions.

Key entities

  • Evergy

    Utility planning Kansas generation additions and seeking Kansas Corporation Commission predetermination approval to serve data-center-driven load growth.

  • Kansas Corporation Commission

    State regulator whose prior approval process enables Evergy to build new generation assets and recover costs through rates.

  • David Campbell

    Evergy CEO discussing the planned predetermination application and data-center load growth in investor remarks.

  • Beale Infrastructure

    Developer with at least one executed energy service agreement under Evergy’s LLPS tariffs in Kansas.

  • Digital Realty

    Developer with at least one executed energy service agreement under Evergy’s LLPS tariffs in Kansas.

Related articles

$EVRGMed

Evergy (EVRG) Q2 2026 Earnings Call Transcript

Evergy (EVRG) Q2 2026 earnings call: adjusted EPS was $0.88 per share and GAAP EPS $0.91 versus $0.74 in 2025, supported by regulated investment recovery and load growth. The company cited 1.8% weather-normalized demand growth, five signed ESAs totaling 2.5 GW, and a $21.6B CapEx plan through 2030. Dividend declared $0.6950.

$EVRGMedAI 8/10

PSC Approves Evergy-Nucor Agreement with Conditions

Missouri PSC approved, with conditions, an amendment between Evergy Missouri West and Nucor Steel Sedalia allowing Nucor to join Evergy’s Business Demand Response (BDR) program. PSC said participation can reduce peak load and costs, but required Evergy to seek prior approval of a firm MW cap for events and to credit or refund if verified benefits do not exceed related costs.

$EVRGMed

Evergy Q2 Earnings Call Highlights

Evergy (NASDAQ:EVRG) Q2 call highlights: management said it expects to sign at least one additional ESA in 2026 and outlined a pipeline of signed, potential and advanced expansion projects. Weather-normalized demand rose 1.8% in Q2 and 3.3% YTD. EPS drivers included $0.10/share from load growth, offset by higher O&M and other items. Evergy’s five-year plan targets $21.6B investment and updated rate-base CAGR to ~12% through 2030.

$EVRGMed

Evergy, Inc. (EVRG): Results of Operations and Financial Condition

Evergy, Inc. (EVRG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE Evergy Announces Second Quarter 2026 Results, Declares Quarterly Dividend and Reaffirms 2026 Guidance • Second Quarter 2026 GAAP EPS of $0.91, compared to $0.74 in 2025 • Second Quarter 2026 Adjusted EPS (non-GAAP) of $0.88, compared to $0.82 in 2025 • D

$MDTMed

Medtronic (MDT) announced CMS granted a New Technology Add-on Payment (NTAP) for its INFUSE™ Bone Graft for TLIF, effective October 1, 2026

Medtronic (MDT) announced CMS granted a New Technology Add-on Payment (NTAP) for its INFUSE™ Bone Graft for TLIF, effective October 1, 2026. NTAP provides additional reimbursement for hospitals using new technologies, supporting adoption and patient access. INFUSE™ is the first and only growth factor technology approved for spine fusion procedures, receiving FDA approval earlier this year. This milestone highlights Medtronic's commitment to advancing healthcare innovation and expanding access to

$PCGMedAI 8/10

Consumer Watchdog Calls On CA Utility Commission For Order To Show Cause Why PG&E Isn't Spending $2 Billion It Was Authorized To Spend On Ratepayer Improvements

Consumer Watchdog urged the California Public Utilities Commission to act against PG&E for not spending $2 billion authorized for infrastructure upgrades. The group claims PG&E is withholding investments despite ratepayer funding, calling it a 'capital strike.' They demand PG&E either invest the money or refund ratepayers, citing past similar actions by the company.